Email Us
Call Us
AUSTIN, Texas – February 24, 2022 – Altogen Labs today highlighted publicly available client referrals from Savara Pharmaceuticals and Terapio Corporation, both of which have gone on record describing their experience working with the Austin-based preclinical CRO. The company today offers over 120 in-house validated CDX and PDX animal models for xenograft efficacy studies, alongside syngeneic and allograft models, patient-derived cell cultures, patient-derived organoids, and new approach methodologies. Both GLP and non-GLP study formats are available, allowing sponsors to run rapid pilot work and pivotal regulatory studies within the same laboratory and the same model system – an advantage when pilot data must translate cleanly into an IND package.
Client referrals and public testimonials are relatively uncommon in the contract research industry. Pharmaceutical and biotechnology sponsors often protect the identities of their outsourcing partners with the same level of discretion they apply to proprietary molecules, novel compounds, development programs, and other confidential research activities. As a result, CRO relationships have very limited public visibility. For this reason, when a pharmaceutical or biotechnology company is willing to speak publicly and discuss its experience with a contract research organization – it represents a meaningful endorsement. A client’s willingness to describe the quality of the scientific collaboration, responsiveness of the research team, ability to meet project milestones, and overall success of the relationship conveys a level of confidence and credibility that traditional marketing claims cannot replicate.
Terapio Corporation and Savara Pharmaceuticals have shared highly positive feedback regarding their experience working with Altogen Labs. Their testimonials highlight successful project execution, effective communication, responsiveness to program requirements, and the ability of the Altogen Labs team to meet critical project goals and timelines. Both organizations spoke favorably about the collaboration and recommended Altogen Labs as a trusted preclinical research partner (client testimonial video: https://www.youtube.com/watch?v=C83LdvCe6u8).
Altogen Labs is a full-service preclinical contract research organization serving pharmaceutical, biotechnology, and academic clients worldwide. The company provides comprehensive preclinical research services designed to support drug discovery and development programs from early-stage feasibility studies through advanced preclinical evaluation. By combining scientific expertise, flexible study design, responsive project management, and a strong commitment to client confidentiality, Altogen Labs works closely with sponsors to advance promising therapeutic candidates efficiently and reliably.
Safety services include acute, sub-chronic, and chronic toxicology, in vivo LD50 determination, and OECD-guideline testing. Efficacy services span tumor growth delay studies, orthotopic and metastatic modeling, bioluminescent imaging, biodistribution, PK/PD, histopathology, biomarker screening, and molecular endpoint analysis by RT-PCR and automated capillary Western.
One hundred percent (100%) of IP (intellectual property) generated in a study belongs to the client.
About Altogen Labs Altogen Labs is a professional, experienced, and highly reputable GLP-compliant contract research organization providing preclinical research and biology CRO services worldwide, with a large collection of validated xenograft models (CDX, PDX, syngeneic, organoids, NAMs) and extensive experience in efficacy xenograft and safety toxicology studies.
Contact Information: Altogen Labs | 11200 Menchaca Rd, Bldg 2, Suite 203 | Austin, TX 78748 USA Tel: 512-433-6177 | Email: info@altogenlabs.com | Web: altogenlabs.com
Source video: youtu.be/C83LdvCe6u8
